Like Countable?

Install the App
TRY NOW

house Bill H.R. 2977

Medicare Coverage for Expenses Related to Insulin Supplies

Argument in favor

Saves Medicare patients money and decreases exposure to dangerous waste.

Argument opposed

Deals only with those Medicare patients who have prescription drug coverage through private insurance companies.

bill Progress


  • Not enacted
    The President has not signed this bill
  • The senate has not voted
  • The house has not voted
      house Committees
      Committee on Energy and Commerce
      Health
      Committee on Ways and Means
    IntroducedAugust 1st, 2013

What is House Bill H.R. 2977?

This bill would cover, under Part D of Medicare, supplies associated with insulin. Specifically, coverage would apply to those supplies associated with the

injection of insulin, of containment, removal, decontamination and disposal of home-generated needles, syringes, and other sharps through a sharps container, decontamination/destruction device[s], or [a] sharps-by-mail program or similar program.

Impact

The bill impacts insulin users who enrolled in Medicare.

Cost of House Bill H.R. 2977

A CBO cost is currently unavailable.

More Information

Media:


Of Note:

Affordable access to insulin varies greatly depending upon what part (B or D) of Medicare is covering that insulin. This Lincoln Journal-Star story provides an excellent example of patient health conflicting with pharmacy profit. 

AKA

Medicare Safe Needle Disposal Coverage Act of 2013

Official Title

To amend title XVIII of the Social Security Act to provide for coverage, as supplies associated with the injection of insulin, of containment, removal, decontamination and disposal of home-generated needles, syringes, and other sharps through a sharps container, decontamination/destruction device, or sharps-by-mail program or similar program under part D of the Medicare program.

    There are currently no opinions on this bill, be the first to add one!